Elevated concentrations of C-reactive protein in subjects with type 2 diabetes mellitus are moderately influenced by glycemic control (Q44479466)

3 December 2017

Elevated concentrations of C-reactive protein in subjects with type 2 diabetes mellitus are moderately influenced by glycemic control (English)

1 reference

3 December 2017

1 reference

M Rodríguez-Morán

1

1 reference

PubMed ID

12809171

3 December 2017

F Guerrero-Romero

series ordinal

2

1 reference

3 December 2017

1 March 2003

1 reference

Journal of Endocrinological Investigation

3 December 2017

1 reference

3 December 2017

26

1 reference

3 December 2017

3

1 reference

3 December 2017

216-221

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03345160

3 December 2017

0 references

cites work

Increased levels of acute-phase serum proteins in diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Is type II diabetes mellitus a disease of the innate immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Body mass index, diabetes, and C-reactive protein among U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345160

Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

21 January 2018

1 reference

12 December 2020

The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects

1 reference

12 December 2020

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

1 reference

12 December 2020

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects

1 reference

12 December 2020

Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population.

1 reference

12 December 2020

Increased levels of C-reactive protein in noncontrolled type II diabetic subjects

1 reference

12 December 2020

Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes

1 reference

12 December 2020

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345160

1 reference

3 December 2017

1 reference

PubMed ID

12809171